Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure

Condition:   Covid19 Intervention:   Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase) Sponsors:   Jon Simmons;   University of South Alabama Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials